Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian
Qin
Q
Key Laboratory of Functional Polymer Materials, Ministry of Education, Institute of Polymer Chemistry, Nankai University, Tianjin 300071, PR China.
Zhang
Chuang-Nian
CN
Wang
Xiu-Hua
XH
Wang
Wei
W
Huang
Wei
W
Cha
Rui-Tao
RT
Wang
Chun-Hong
CH
Yuan
Zhi
Z
Liu
Min
M
Wan
Hai-Ying
HY
Tang
Hua
H
D000818:Animals; D045744:Cell Line, Tumor; D048271:Chitosan / Q000737:chemistry*; D004317:Doxorubicin / Q000008:administration & dosage / Q000737:chemistry; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry*; D006034:Glycyrrhetinic Acid / Q000737:chemistry*; D006801:Humans; D007267:Injections; D008099:Liver / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry* / Q000648:ultrastructure*; D011092:Polyethylene Glycols / Q000737:chemistry*; D017550:Spectroscopy, Fourier Transform Infrared
D004337:Drug Carriers; D011092:Polyethylene Glycols; D004317:Doxorubicin; D048271:Chitosan; D006034:Glycyrrhetinic Acid